Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared on X:
“What an energizing LIVE molecular tumor board at the WIN Symposium, Providence, RI, world‑class precision oncology faculty tackling real and challenging cases in real time Razelle Kurzrock, Wafik S. El-Deiry, Bicky Thapa, Sewanti Limaye.
Imagine if every patient everywhere had access to this level of expert discussion and insight.”
You can also read: Vivek Subbiah: Honored to Receive the “Leadership in Cancer Drug Development 2026” Award at WIN Symposium
